iKang Healthcare Group Inc(ADR) (NASDAQ:KANG) reported ($0.77) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.13) by $0.64. The company had revenue of $29.50 million for the quarter, compared to the consensus estimate of $23.37 million. iKang Healthcare Group Inc(ADR)’s revenue was up 60.3% compared to the same quarter last year. Analysts expect that iKang Healthcare Group In will post $0.50 EPS for the current fiscal year. iKang Healthcare Group Inc(ADR) (NASDAQ:KANG) net profit margin is -22.30% and weekly performance is 17.29%. On last trading day company shares ended up $17.77. Analysts mean target price for the company is $16.88. iKang Healthcare Group Inc(ADR) (NASDAQ:KANG) distance from 50-day simple moving average (SMA50) is 25.33%.
On 3 JUNE Omeros Corporation (NASDAQ:OMER) announced Omidria 1%/0.3% has been approved by the U.S. Food and Drug Administration (FDA) for reducing postoperative pain during cataract surgery or intraocular lens replacement (ILR) and maintaining pupil size by preventing intraoperative miosis (pupil constriction). Omeros Corporation (NASDAQ:OMER) shares fell -2.06% in last trading session and ended the day on $15.18. OMER return on assets is -170.50%. Omeros Corporation (NASDAQ:OMER) quarterly performance is 23.50%.
Applied Genetic Technologies Corp (NASDAQ:AGTC) reported ($25.45) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.37) by $25.08. The company had revenue of $0.23 million for the quarter, compared to the consensus estimate of $0.15 million. Analysts expect that Applied Genetic Technologies Corp will post $-14.11 EPS for the current fiscal year. Applied Genetic Technologies Corp (NASDAQ:AGTC) shares moved down -4.90% in last trading session and was closed at $24.05, while trading in range of $21.66 – $26.81. Applied Genetic Technologies Corp (NASDAQ:AGTC) year to date (YTD) performance is 62.94%.
On 5 JUNE Tornier NV (NASDAQ:TRNX) reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.03. The company had revenue of $89.00 million for the quarter, compared to the consensus estimate of $80.41 million. During the same quarter in the previous year, the company posted ($0.17) earnings per share. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. Analysts expect that Tornier N.V. will post $-0.45 EPS for the current fiscal year. Tornier NV (NASDAQ:TRNX) ended the last trading day at $22.51. Company weekly volatility is calculated as 2.58% and price to cash ratio as 22.26. Tornier NV (NASDAQ:TRNX) showed a positive/negative weekly performance of 5.50%.
On 23 MAY China Biologic Products Inc (NASDAQ:CBPO) reported $0.69 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.47 by $0.22. The company had revenue of $56.27 million for the quarter, compared to the consensus estimate of $51.40 million. Analysts expect that China Biologic Products will post $2.60 EPS for the current fiscal year. China Biologic Products Inc (NASDAQ:CBPO) net profit margin is 33.90% and weekly performance is 4.64%. On last trading day company shares ended up $48.06. Analysts mean target price for the company is $51.00. China Biologic Products Inc (NASDAQ:CBPO) distance from 50-day simple moving average (SMA50) is 20.66%.